J.P. Bru

2.2k total citations · 1 hit paper
45 papers, 925 citations indexed

About

J.P. Bru is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, J.P. Bru has authored 45 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 12 papers in Pharmacology and 8 papers in Molecular Medicine. Recurrent topics in J.P. Bru's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Pneumonia and Respiratory Infections (11 papers) and Antibiotic Resistance in Bacteria (8 papers). J.P. Bru is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Pneumonia and Respiratory Infections (11 papers) and Antibiotic Resistance in Bacteria (8 papers). J.P. Bru collaborates with scholars based in France, Belgium and Japan. J.P. Bru's co-authors include J.‐P. Stahl, R. Gauzit, Philippe Lesprit, A. Therby, Valérie Zeller, Vincent Le Moing, Denis Mulleman, Damien Bouhour, Idir Ghout and É. Denes and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

J.P. Bru

44 papers receiving 886 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial

2014 315 citations Philippe Lesprit, J.P. Bru et al. profile →

Peers

Countries citing papers authored by J.P. Bru

Since Specialization

Citations

This map shows the geographic impact of J.P. Bru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Bru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Bru more than expected).

Fields of papers citing papers by J.P. Bru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Bru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Bru. The network helps show where J.P. Bru may publish in the future.

Co-authorship network of co-authors of J.P. Bru

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Bru. A scholar is included among the top collaborators of J.P. Bru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Bru. J.P. Bru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The role of systemic corticosteroids when treating infections in adult primary care 2024 ·Infectious Diseases Now ·J.P. Bru	2
2	How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies 2024 ·International Journal of Technology Assessment in Health Care ·(unknown), Étienne Lengliné, (unknown), J.P. Bru, Séverine Ansart, E. Aslangul, (unknown), Pierre Cochat, Sylvie Chevret, (unknown)	2
3	Defining standard and high dosages for β-lactam agents administered by intermittent, prolonged or continuous infusion: a PK/PD simulation study 2023 ·Journal of Antimicrobial Chemotherapy ·Sylvain Goutelle, Vincent Jullien, J.P. Bru, Vincent Cattoir, R. Gauzit, Philippe Lesprit, Gérard Lina, Frédéric Schramm, Étienne Canouï, R. Lepeule	3
4	Treatment of Coxiella burnetii endocarditis with hydroxychloroquine. Is it evidence-based? 2022 ·Clinical Microbiology and Infection ·J.‐P. Stahl, Emmanuelle Varon, J.P. Bru	5
5	Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations 2021 ·Infectious Diseases Now ·R. Gauzit, Bernard Castan, É. Bonnet, J.P. Bru, Robert Cohen, S. Diamantis, Albert Faye, Hikombo Hitoto, Nahéma Issa, David Lebeaux, Philippe Lesprit, Laurence Maulin, (unknown), (unknown), C. Strady, Emmanuelle Varon, Renaud Verdon, Fanny Vuotto, Charlotte Welker, J.‐P. Stahl	20
6	Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections 2019 ·Médecine et Maladies Infectieuses ·J.P. Bru, S. Alfandari, Alexandre Bleibtreu, P. Chavanet, R. Gauzit, Xavier Lescure, Philippe Lesprit, Pierre Tattevin	2
7	Application of guidelines for aminoglycosides use in French hospitals in 2013–2014 2017 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), J. Robert, Y. Péan, S. Alfandari, J.P. Bru, J. P. Bédos, Christian Rabaud, R. Gauzit	7
8	Prise en charge des infections intra-abdominales 2015 ·Anesthésie & Réanimation ·Philippe Montravers, Hervé Dupont, Marc Léone, Jean Michel Constantin, Paul‐Michel Mertès, Pierre‐François Laterre, Benoît Misset, J.P. Bru, R. Gauzit, Albert Sotto, Cécile Brigand, A. Hamy, Jean‐Jacques Tuech	11
9	Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study 2015 ·Médecine et Maladies Infectieuses ·S. Alfandari, J. Robert, Y. Péan, Christian Rabaud, J. P. Bédos, Emmanuelle Varon, Alain Lepape, J.P. Bru, R. Gauzit	16
10	Carbapenem use in French hospitals: A nationwide survey at the patient level 2015 ·International Journal of Antimicrobial Agents ·R. Gauzit, Y. Péan, S. Alfandari, J.P. Bru, Jean‐Pierre Bédos, Christian Rabaud, J. Robert	18
11	Guidelines for management of intra-abdominal infections 2015 ·Anaesthesia Critical Care & Pain Medicine ·Philippe Montravers, Hervé Dupont, Marc Léone, Jean‐Michel Constantin, Paul‐Michel Mertès, Pierre‐François Laterre, Benoît Misset, J.P. Bru, R. Gauzit, Albert Sotto, Cécile Brigand, A. Hamy, Jean‐Jacques Tuech	87
12	Adult patients hospitalized for measles in France, in the 21st century 2013 ·Médecine et Maladies Infectieuses ·J.‐P. Stahl, Dominique Salmon, Fabrice Bruneel, Éric Caumes, F. Freymuth∘, J.P. Bru, Patrice Morand, F. Roblot, J.L. Schmit, C. Strady, Jean‐François Timsit, Christian Rabaud	14
13	Point prevalence survey of antibiotic use in French hospitals in 2009 2012 ·Journal of Antimicrobial Chemotherapy ·J. Robert, Y. Péan, Emmanuelle Varon, J.P. Bru, J. P. Bédos, Xavier Bertrand, Alain Lepape, J.‐P. Stahl, R. Gauzit, (unknown)	53
14	Uvéites de Lyme : à propos de 2 observations 2010 ·Archives de Pédiatrie ·Jean Camille Mattei, Philippe Pélissier, Odile Richard, (unknown), (unknown), C. Cazorla, J.P. Bru, JL Stéphan	2
15	Is there a rationale for the continuous infusion of cefepime? A multidisciplinary approach 2003 ·Clinical Microbiology and Infection ·E Bernard, Dominique Breilh, J.P. Bru, D. Chiche, (unknown), R. Garraffo, F. W. Goldstein, (unknown), G. Potel	13
16	Adénocarcinomes d'origine inconnue à manifestation thoracique et VIH : à propos de quatre cas 1999 ·La Revue de Médecine Interne ·(unknown), Claire Martin, (unknown), J.P. Bru, J. Gaillat	4
17	Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumonia 1994 ·European Journal of Clinical Microbiology & Infectious Diseases ·J. Gaillat, J.P. Bru, A Sédallian	11
18	Traitement des méningo-encéphalites à Listeria monocytogenes de l'adulte par le cotrimoxazole en monothérapie 1988 ·La Revue de Médecine Interne ·(unknown), J.‐P. Stahl, J.P. Bru, J. Croizé, M. Micoud	4
19	Accès pernicieux palustre. Evolution rapidement favorable après exsanguino-transfusion. 1986 ·La Presse Médicale ·(unknown), J.P. Bru, F. Carpentier, M. Micoud, (unknown)	3
20	[Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions]. 1985 ·PubMed ·J. Gaillat, (unknown), Marie‐Reine Mallaret, (unknown), J.P. Bru, J.‐P. Stahl, (unknown), (unknown)	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact